Figure 1.
Effects of Probenecid on viability and morphology of HepG2 cells. (A) Cells were treated with Probenecid at different concentrations (250, 500, and 1,000 μM) for 24 and 48 h. Data are expressed as a percentage of the control group and presented as the means ± SD of three replicates from three independent experiments. *p < 0.05, ***p < 0.001, Student's t-test. (B) Representative images of Probenecid-treated HepG2 cells. DMSO-treated cells were used as control.